Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 14, 2026
Fibrosis progression rate and comparison of paired liver biopsy versus non-invasive tests as surrogate endpoints for clinical trials in MetALD and ALD
Ellen Lyngbeck Jensen, Maja Thiele, Nikolaj Torp, et al.
JHEP Reports : Innovation in Hepatology
|
April 5, 2026
Alcohol-Related Liver Disease Disrupts Bile Acid Homeostasis and Gut Microbial Bile Acid Metabolism
Marisa Isabell Keller, Andressa de Zawadzki, Maja Thiele, et al.
Annals of Internal Medicine
|
December 12, 2022
Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease : A Randomized Controlled Trial
Camilla Dalby Hansen, Eva-Marie Gram-Kampmann, Johanne Kragh Hansen, et al.
Gastroenterology
|
February 27, 2023
Sphingolipids Are Depleted in Alcohol-Related Liver Fibrosis
Maja Thiele, Tommi Suvitaival, Kajetan Trošt, et al.
The Lancet. Gastroenterology & Hepatology
|
December 14, 2024
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study
Katrine P Lindvig, Katrine H Thorhauge, Johanne K Hansen, et al.
Journal of Hepatology
|
March 29, 2024
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases
Maja Thiele, Ida Falk Villesen, Lili Niu, et al.
Cell
|
November 14, 2024
Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associations
Suguru Nishijima, Evelina Stankevic, Oliver Aasmets, et al.
Nature Communications
|
July 2, 2025
The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial
Johanne K Hansen, Mads Israelsen, Suguru Nishijima, et al.
JHEP Reports : Innovation in Hepatology
|
December 1, 2025
PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort study
Adrià Juanola, Gabriel Mezzano, Elisa Pose, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 14, 2026
Fibrosis progression rate and comparison of paired liver biopsy versus non-invasive tests as surrogate endpoints for clinical trials in MetALD and ALD
Ellen Lyngbeck Jensen, Maja Thiele, Nikolaj Torp, et al.
JHEP Reports : Innovation in Hepatology
|
April 5, 2026
Alcohol-Related Liver Disease Disrupts Bile Acid Homeostasis and Gut Microbial Bile Acid Metabolism
Marisa Isabell Keller, Andressa de Zawadzki, Maja Thiele, et al.
Annals of Internal Medicine
|
December 12, 2022
Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease : A Randomized Controlled Trial
Camilla Dalby Hansen, Eva-Marie Gram-Kampmann, Johanne Kragh Hansen, et al.
Gastroenterology
|
February 27, 2023
Sphingolipids Are Depleted in Alcohol-Related Liver Fibrosis
Maja Thiele, Tommi Suvitaival, Kajetan Trošt, et al.
The Lancet. Gastroenterology & Hepatology
|
December 14, 2024
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study
Katrine P Lindvig, Katrine H Thorhauge, Johanne K Hansen, et al.
Journal of Hepatology
|
March 29, 2024
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases
Maja Thiele, Ida Falk Villesen, Lili Niu, et al.
Cell
|
November 14, 2024
Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associations
Suguru Nishijima, Evelina Stankevic, Oliver Aasmets, et al.
Nature Communications
|
July 2, 2025
The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial
Johanne K Hansen, Mads Israelsen, Suguru Nishijima, et al.
JHEP Reports : Innovation in Hepatology
|
December 1, 2025
PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort study
Adrià Juanola, Gabriel Mezzano, Elisa Pose, et al.
Page
of 7